Intravenous administration of the nanomedicine resulted in an increase in localized enrichment of metformin and Mn2+ in cancer cells, both of which synergistically upregulated the cGAS-STING pathway and enhanced T cell tumor-killing ability 145. This evidence concerns the gene STING1 and neoplasm.